Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MREO |
---|---|---|
09:32 ET | 2101 | 2.995 |
09:34 ET | 2095 | 2.98 |
09:36 ET | 1125 | 2.99 |
09:38 ET | 5934 | 2.99 |
09:39 ET | 5300 | 2.995 |
09:41 ET | 8800 | 2.995 |
09:43 ET | 3678 | 3.03 |
09:45 ET | 1100 | 3.01 |
09:48 ET | 1936 | 3 |
09:50 ET | 600 | 3 |
09:52 ET | 2587 | 3.02 |
09:54 ET | 2405 | 3.02 |
09:56 ET | 1500 | 3.01 |
09:57 ET | 1600 | 3 |
09:59 ET | 4118 | 3.0087 |
10:01 ET | 2700 | 2.995 |
10:03 ET | 1774 | 2.98 |
10:06 ET | 6547 | 2.9801 |
10:08 ET | 8900 | 2.978 |
10:10 ET | 5910 | 2.95 |
10:12 ET | 4897 | 2.95 |
10:14 ET | 16592 | 2.945 |
10:15 ET | 2501 | 2.955 |
10:17 ET | 1100 | 2.955 |
10:19 ET | 3869 | 2.955 |
10:21 ET | 2910 | 2.9599 |
10:24 ET | 1800 | 2.965 |
10:26 ET | 10900 | 2.965 |
10:28 ET | 7690 | 2.9507 |
10:30 ET | 7934 | 2.9499 |
10:32 ET | 3244 | 2.935 |
10:33 ET | 4890 | 2.955 |
10:35 ET | 1000 | 2.955 |
10:37 ET | 675 | 2.955 |
10:39 ET | 2710 | 2.95 |
10:42 ET | 211 | 2.94 |
10:44 ET | 300 | 2.94 |
10:46 ET | 200 | 2.94 |
10:50 ET | 3000 | 2.9498 |
10:55 ET | 3500 | 2.945 |
10:57 ET | 2200 | 2.955 |
11:00 ET | 2619 | 2.95 |
11:02 ET | 300 | 2.95 |
11:04 ET | 300 | 2.95 |
11:06 ET | 400 | 2.95 |
11:08 ET | 2800 | 2.95 |
11:09 ET | 300 | 2.95 |
11:11 ET | 6410 | 2.95 |
11:13 ET | 1295 | 2.95 |
11:18 ET | 200 | 2.945 |
11:20 ET | 5297 | 2.935 |
11:22 ET | 300 | 2.93 |
11:24 ET | 1200 | 2.9342 |
11:26 ET | 18078 | 2.92 |
11:27 ET | 40761 | 2.885 |
11:29 ET | 2450 | 2.8896 |
11:31 ET | 17038 | 2.915 |
11:33 ET | 13882 | 2.915 |
11:36 ET | 12086 | 2.9 |
11:38 ET | 2603 | 2.9 |
11:40 ET | 2600 | 2.9 |
11:42 ET | 3260 | 2.9 |
11:44 ET | 2736 | 2.9 |
11:45 ET | 1458 | 2.9 |
11:47 ET | 11899 | 2.89 |
11:49 ET | 2450 | 2.91 |
11:51 ET | 239 | 2.91 |
11:56 ET | 100 | 2.905 |
11:58 ET | 772 | 2.9 |
12:00 ET | 1280 | 2.9074 |
12:02 ET | 1200 | 2.905 |
12:05 ET | 200 | 2.905 |
12:09 ET | 5025 | 2.9105 |
12:12 ET | 2125 | 2.915 |
12:14 ET | 4106 | 2.925 |
12:16 ET | 1600 | 2.93 |
12:18 ET | 333 | 2.938 |
12:20 ET | 1000 | 2.945 |
12:25 ET | 250 | 2.94 |
12:27 ET | 4521 | 2.945 |
12:32 ET | 200 | 2.95 |
12:34 ET | 1381 | 2.95 |
12:36 ET | 10155 | 2.96 |
12:43 ET | 2100 | 2.97 |
12:45 ET | 100 | 2.965 |
12:48 ET | 300 | 2.965 |
12:50 ET | 545 | 2.97 |
12:52 ET | 1068 | 2.97 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Mereo BioPharma Group PLC | 426.4M | -11.2x | --- |
Compass Pathways PLC | 538.2M | -3.3x | --- |
Oculis Holding AG | 495.6M | -6.6x | --- |
Altimmune Inc | 545.9M | -5.0x | --- |
Erasca Inc | 559.3M | -3.0x | --- |
Olema Pharmaceuticals Inc | 523.5M | -4.6x | --- |
Mereo BioPharma Group plc is a biopharmaceutical company. It is focused on the development of therapeutics for rare diseases. It has developed a portfolio of clinical-stage product candidates. The Company has two rare disease product candidates: setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for the treatment of severe alpha-1-antitrypsin deficiency-associated lung disease (AATD-LD) and bronchiolitis obliterans syndrome (BOS). It also has two oncology product candidates in clinical development. It also includes Etigilimab, an antibody against TIGIT (T-cell immunoreceptor with Ig and ITIM domains). Its non-core partnered programme, Navicixizumab, is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Its non-core programs available for partnership include Acumapimod and Leflutrozole. Acumapimod is a p38 MAP kinase inhibitor therapy for treatment during severe acute exacerbations of COPD (AECOPD).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $426.4M |
---|---|
Revenue (TTM) | $9.1M |
Shares Outstanding | 140.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.68 |
EPS | $-0.27 |
Book Value | $0.63 |
P/E Ratio | -11.2x |
Price/Sales (TTM) | 47.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -444.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.